NCT00607841 2019-05-06A Study of Ispinesib in Metastatic Breast CancerCytokineticsPhase 1 Terminated16 enrolled
NCT00136578 2017-09-25Ispinesib In Combination With Carboplatin In Patients With Solid TumorsGlaxoSmithKlinePhase 1 Completed30 enrolled
NCT00363272 2013-01-16Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or LymphomaNational Cancer Institute (NCI)Phase 1 Completed30 enrolled
NCT00101244 2013-01-14SB-715992 in Treating Patients With Metastatic or Unresectable Solid Tumors or Hodgkin's or Non-Hodgkin's LymphomaNational Cancer Institute (NCI)Phase 1 Terminated31 enrolled
NCT00098826 2013-01-11SB-715992 in Treating Patients With Acute Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic SyndromesNational Cancer Institute (NCI)Phase 1 Completed40 enrolled
NCT00119171 2008-10-16Ispinesib In Combination With Capecitabine In Patients With Solid TumorsGlaxoSmithKlinePhase 1 Completed30 enrolled
NCT00169520 2008-10-16SB-715992 In Combination With Docetaxel In Patients With Solid TumorsGlaxoSmithKlinePhase 1 Completed30 enrolled